Change in number of shares and votes in IRLAB Therapeutics AB

During August 2025, the registered number of shares and votes in IRLAB Therapeutics AB (”IRLAB”) has increased as a result of the rights issue of shares of series A which was resolved by the Board of Directors on 24 June 2025, by virtue of the authorization from the Annual General Meeting on 11 June 2025.

IRLAB publishes interim report for the period January – June 2025

IRLAB: Invitation to the interim report for Q2 2025 presentation and webcast